Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Candel Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2023 4 Gaeta Renee (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Nguyen Diem (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 PAPA JOSEPH C (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Aguilar-Cordova Estuardo (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/29/2023 4 Nabel Gary J. (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $1.22, valued at $17.4k
06/09/2023 4 Loggia Nicoletta (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 28,480 options to buy @ $1.51, valued at $43k
06/09/2023 3 Loggia Nicoletta (Director) has filed a Form 3 on Candel Therapeutics, Inc.
05/02/2023 4 Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $1.29, valued at $232.2k
05/02/2023 4 Tyagarajan Seshu (Chief Technology Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $1.29, valued at $116.1k
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $1.29, valued at $116.1k
12/12/2022 4 Barone Francesca (Chief Scientific Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 1,238 shares @ $1.61, valued at $2k
12/12/2022 4 PAPA JOSEPH C (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 3,014 shares @ $1.7, valued at $5.1k
Bought 35,018 shares @ $1.94, valued at $67.9k
12/12/2022 4 Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 3,050 shares @ $1.68, valued at $5.1k
Bought 23,950 shares @ $1.92, valued at $46k
12/12/2022 4 Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 3,050 shares @ $1.7, valued at $5.2k
Bought 12,935 shares @ $1.92, valued at $24.8k
12/12/2022 4 Tyagarajan Seshu (Chief Technology Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 3,000 shares @ $1.69, valued at $5.1k
Bought 10,358 shares @ $1.93, valued at $20k
12/12/2022 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Bought 3,100 shares @ $1.69, valued at $5.2k
Bought 2,468 shares @ $1.93, valued at $4.8k
11/30/2022 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 90,877 shares @ $0
11/30/2022 4 Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 195,906 shares @ $0
11/30/2022 4 Barone Francesca (Chief Scientific Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 90,877 shares @ $0
11/30/2022 4 Nichols William Garrett (Chief Medical Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 58,479 shares @ $0
11/30/2022 4 Tyagarajan Seshu (See Remarks) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 73,684 shares @ $0
10/17/2022 4 Aguilar-Cordova Estuardo (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $2.81, valued at $40k
10/17/2022 4 Nguyen Diem (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $2.81, valued at $40k
10/17/2022 4 Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $2.81, valued at $40k
10/17/2022 4 Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $2.81, valued at $40k
10/17/2022 4 Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 14,240 options to buy @ $2.81, valued at $40k
09/23/2022 4 Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 230,000 options to buy @ $3.21, valued at $738.3k
09/23/2022 3 Amello Jason (CFO) has filed a Form 3 on Candel Therapeutics, Inc.
09/14/2022 4 Nichols William Garrett (Chief Medical Officer) has filed a Form 4 on Candel Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $3.75, valued at $750k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy